National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 51280 [2010-20612]
Download as PDF
<![CDATA[
51280
Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
emcdonald on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biology of Macromolecular
Assemblies.
Date: September 1, 2010.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rolf Menzel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
MSC 7808, Bethesda, MD 20892, 301–435–
0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cellular and Molecular Aspects of
Neurodevelopment.
Date: September 9, 2010.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Laurent Taupenot, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4811,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Investigations on Primary Immunodeficiency
Diseases.
Date: September 28, 2010.
Time: 11 a.m. to 5 pm.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Scott Jakes, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
VerDate Mar<15>2010
17:05 Aug 18, 2010
Jkt 220001
Drive, Room 4198, MSC 7812, Bethesda, MD
20892, 301–495–1506, jakesse@mail.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Cellular and
Molecular Immunology—A Study Section.
Date: September 30–October 1, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington, DC, 923
16th Street, NW., Washington, DC 20006.
Contact Person: David B. Winter, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Immunology IRG, 4th Floor, Rm.
4204, 6701 Rockledge Drive, RKII, Bethesda,
MD 20892, 301–435–1152,
dwinter@mail.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Transplantation,
Tolerance, and Tumor Immunology Study
Section.
Date: September 30–October 1, 2010.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Melrose Hotel, 2430
Pennsylvania Avenue, NW., Washington, DC
20037.
Contact Person: Jin Huang, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4199, MSC 7812, Bethesda, MD
20892, 301–435–1230, jh377p@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Nonhuman Primate Core
Humoral Immunology Vaccine Laboratory.
Date: September 9, 2010.
Time: 12:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Jay Bruce Sundstrom, PhD,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drvie, MSC–7616, Room 3119,
Bethesda, MD 20892–7616, 301–496–2550,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 13, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–20612 Filed 8–18–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0274]
Dated: August 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Oversight of Laboratory Developed
Tests; Public Meeting; Reopening of
the Comment Period
[FR Doc. 2010–20584 Filed 8–18–10; 8:45 am]
AGENCY:
BILLING CODE 4140–01–P
Food and Drug Administration,
HHS.
Notice; reopening of the
comment period.
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
The Food and Drug
Administration (FDA) is reopening until
September 15, 2010, the comment
period for the notice that published in
the Federal Register of Thursday, June
17, 2010 (75 FR 34463). In the notice,
FDA requested input and comments
from interested stakeholders on the
agency’s oversight of laboratory
developed tests (LDTs). FDA is
reopening the comment period to
update comments and to receive any
new information.
DATES: Submit either electronic or
written comments and information by
September 15, 2010.
ADDRESSES: Submit electronic
comments or information to https://
www.regulations.gov. Submit written
comments or information to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
SUMMARY:
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 75, Number 160 (Thursday, August 19, 2010)]
[Notices]
[Page 51280]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-20612]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Nonhuman Primate Core Humoral
Immunology Vaccine Laboratory.
Date: September 9, 2010.
Time: 12:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Jay Bruce Sundstrom, PhD, Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drvie, MSC-7616, Room 3119, Bethesda, MD 20892-7616, 301-
496-2550, sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 13, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20612 Filed 8-18-10; 8:45 am]
BILLING CODE 4140-01-P
